Skip to main content
Eugene Shenderov, MD, Oncology, Baltimore, MD

EugeneShenderovMDD.Phil., F.A.C.P.(He/Him)

Oncology Baltimore, MD

Genitourinary Oncology

Assistant Professor of Oncology and Cancer Research Immunology

Dr. Shenderov is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Shenderov's full profile

Already have an account?

  • Office

    1650 Orleans St
    # CRB1
    Baltimore, MD 21287
    Phone+1 410-614-4459
    Fax+1 410-367-2194

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2016 - 2018
  • Johns Hopkins University/Bayview Medical Center
    Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 2013 - 2016
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2013, MD
  • University of Oxford
    University of OxfordD.Phil, Tumour Immunology, 2005 - 2009

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2023 - 2027
  • VA State Medical License
    VA State Medical License 2023 - 2026
  • MD State Medical License
    MD State Medical License 2016 - 2025
  • PA State Medical License
    PA State Medical License 2024 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Phase II neoadjuvant and immunologic study of B7-H3 targeting with enoblituzumab in localized intermediate- and high-risk prostate cancer. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • Immunotherapy Could Be Effective for Treating Prostate Cancer: Study
    Immunotherapy Could Be Effective for Treating Prostate Cancer: StudyApril 9th, 2023
  • Health News | Immunotherapy Could Be Effective for Treatment of Prostate Cancer: Study
    Health News | Immunotherapy Could Be Effective for Treatment of Prostate Cancer: StudyApril 9th, 2023
  • Study Shows How Novel Immunotherapy Helps Fight High-Risk Prostate Cancer, ET HealthWorld
    Study Shows How Novel Immunotherapy Helps Fight High-Risk Prostate Cancer, ET HealthWorldApril 8th, 2023
  • Join now to see all